Cargando…

Is Surgical Treatment an Option for Locally Advanced Cervical Cancer in the Presence of Central Residual Tumor after Chemoradiotherapy?

Objective To evaluate the outcomes of surgical treatment in patients with chemoradiotherapy (CRT)-resistant and locally advanced cervical cancer (LACC). Methods Patients with LACC who underwent surgery due to resistance to CRT between 2005 and 2015 were reviewed retrospectively. Disease-free surviva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Topuz, Samet, Kaban, Alpaslan, Küçücük, Seden, Salihoglu, Yavuz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thieme Revinter Publicações Ltda 2020
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316869/ https://www.ncbi.nlm.nih.gov/pubmed/32107764 http://dx.doi.org/10.1055/s-0040-1701459

Ejemplares similares

In patients with advanced ovarian cancer, primary suboptimal surgery has better survival outcome than interval suboptimal surgery
por: Kaban, Alpaslan, et al.
Publicado: (2019)

Clinicopathologic and survival results in serous endometrium carcinoma and subgroup analysis for mixed serous and pure serous histology
por: Kaban, Alpaslan, et al.
Publicado: (2018)

Investigation of Extra-Uterine Tumor Dissemination of Endometrial Cancers with Myometrial Invasion Less Than 50% According to Histologic Subtypes
por: Kaban, Alpaslan, et al.
Publicado: (2019)

High expression of SALL4 and fascin, and loss of E-cadherin expression in undifferentiated/dedifferentiated carcinomas of the endometrium: An immunohistochemical and clinicopathologic study
por: Onder, Semen, et al.
Publicado: (2017)

Comparison of Pathological Prognostic Stage and Anatomic Stage Groups According to the Updated Version of the American Joint Committee on Cancer (AJCC) Breast Cancer Staging 8(th) Edition
por: Ibis, Kamuran, et al.
Publicado: (2018)

The etiology of adnexal masses in women with a history of non-gynaecological malignancy: recurrence, second, primary or none?
por: Çeliksoy, Harika Yumru, et al.
Publicado: (2022)

A Retrospective Clinical Analysis of Hyperthermic Intraperitoneal Chemotherapy in Gynecological Cancers: Technical Details, Tolerability, and Efficacy
por: Minareci, Yagmur, et al.
Publicado: (2020)

Surgical management of squamous cell vulvar cancer without clitoris, urethra or anus involvement
por: Kaban, Alpaslan, et al.
Publicado: (2017)

Effect of Lymphadenectomy on Survival in Early-Stage Type II Endometrial Carcinoma and Carcinosarcoma
por: Vatansever, Dogan, et al.
Publicado: (2020)

Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option
por: Meulendijks, D, et al.
Publicado: (2014)

Treatment results of incomplete chemoradiotherapy in locally advanced cervical cancer
por: Gao, Ying, et al.
Publicado: (2013)

Concurrent Chemoradiotherapy without Brachytherapy in Locally Advanced Cervical Cancer
por: Kadkhodayan, Sima, et al.
Publicado: (2013)

Extrafascial hysterectomy after concurrent chemoradiotherapy in locally advanced cervical adenocarcinoma
por: Yang, Jie, et al.
Publicado: (2016)

Endostar, an Antiangiogenesis Inhibitor, Combined With Chemoradiotherapy for Locally Advanced Cervical Cancer
por: Lu, Heming, et al.
Publicado: (2022)

Chemoradiotherapy alone vs. chemoradiotherapy and hysterectomy for locally advanced cervical cancer: A systematic review and updated meta-analysis
por: Lu, Weijia, et al.
Publicado: (2021)

Surgical issues in locally advanced rectal cancer treated by preoperative chemoradiotherapy
por: Lim, Seok-Byung, et al.
Publicado: (2013)

Adjuvant hysterectomy in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy
por: Shim, Seung-Hyuk
Publicado: (2019)

Effectiveness of Concomitant Chemoradiotherapy with Gemcitabine in Locally Advanced Cervical Cancer Patients with Comorbidities
por: Brau-Figueroa, Hasan, et al.
Publicado: (2022)

Efficacy and safety of nimotuzumab combined with chemoradiotherapy in the treatment of locally advanced cervical cancer
por: Zhang, Lei, et al.
Publicado: (2022)

Is there any correlation between TNF-related apoptosis-inducing ligand (TRAIL) genetic variants and breast cancer?
por: Yildiz, Yemliha, et al.
Publicado: (2010)

Current Treatment Options for Local Residual Nasopharyngeal Carcinoma
por: Stoker, S. D., et al.
Publicado: (2013)

Cost-effectiveness of para-aortic lymphadenectomy before chemoradiotherapy in locally advanced cervical cancer
por: Lee, Jung-Yun, et al.
Publicado: (2015)

Safety and efficacy of nimotuzumab combined with chemoradiotherapy in Chinese patients with locally advanced cervical cancer
por: Chen, Yong-Fa, et al.
Publicado: (2017)

Epithelial–mesenchymal transition, proliferation, and angiogenesis in locally advanced cervical cancer treated with chemoradiotherapy
por: Rojas‐Puentes, Leonardo, et al.
Publicado: (2016)

Analysis of Treatment Outcomes and Prognosis After Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer
por: Peng, Qing-he, et al.
Publicado: (2022)

Outcomes and prognostic factors in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy
por: Liu, Jing, et al.
Publicado: (2022)

Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trial
por: Rodrigues, Manuel, et al.
Publicado: (2023)

Adding Adjuvants to Fluoropyrimidine-based Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: An Option Worthy of Serious Consideration
por: Wu, Fengpeng, et al.
Publicado: (2021)

Metaplastic Breast Carcinoma Versus Triple-Negative Breast Cancer: Survival and Response to Treatment
por: Aydiner, Adnan, et al.
Publicado: (2015)

Clinical Impact of Pathologic Residual Tumor in Locally Advanced Cervical Cancer Patients Managed by Chemoradiotherapy Followed by Radical Surgery: A Large, Multicenter, Retrospective Study
por: Federico, Alex, et al.
Publicado: (2022)

Salvage high intensity focused ultrasound for residual or recurrent cervical cancer after definitive chemoradiotherapy
por: Zhong, Qin, et al.
Publicado: (2022)

Individualized pelvic lymphadenectomy should follow neoadjuvant concurrent chemoradiotherapy for locally advanced cervical cancer
por: Wei, Li-Chun, et al.
Publicado: (2018)

Clinical significance of lymph node size in locally advanced cervical cancer treated with concurrent chemoradiotherapy
por: Oh, Jinju, et al.
Publicado: (2019)

Muscle Loss after Chemoradiotherapy as a Biomarker of Distant Failures in Locally Advanced Cervical Cancer
por: Lee, Jie, et al.
Publicado: (2020)

Completion pneumonectomy and chemoradiotherapy as treatment options in local recurrence of non-small-cell lung cancer
por: Kasprzyk, Mariusz, et al.
Publicado: (2015)

Concurrent chemoradiotherapy followed by adjuvant chemotherapy versus concurrent chemoradiotherapy alone in locally advanced cervical cancer: A systematic review and meta-analysis
por: Liu, Haonan, et al.
Publicado: (2022)

Correlation between hematological parameters and outcome in patients with locally advanced cervical cancer treated by concomitant chemoradiotherapy
por: Gennigens, Christine, et al.
Publicado: (2020)

Concurrent Chemoradiotherapy Increases the Levels of Soluble Immune Checkpoint Proteins in Patients with Locally Advanced Cervical Cancer
por: Liu, Chao, et al.
Publicado: (2022)

A novel gene signature associated with poor response to chemoradiotherapy in patients with locally advanced cervical cancer
por: Kim, Kyung Hwan, et al.
Publicado: (2021)

The value of metabolic parameters and textural analysis in predicting prognosis in locally advanced cervical cancer treated with chemoradiotherapy
por: Pedraza, Sara, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2tslpq5p97g4g3b73qbirqj1jo